Welcome to the EPA 2022 Interactive Programme 

The congress will officially run on Central European Summer Time (CEST/GMT +2) 

To convert the congress times to your local time Click Here 

 

Icon

Description automatically generatedFully Live with Live Q&A Icon

Description automatically generatedOn Demand (available from 4 June)  Icon

Description automatically generatedECP Session Icon

Description automatically generatedSection Session Icon

Description automatically generated EPA Course (Pre-Registration Required) 

 

  Ask the Expert      Sessions with Voting      Live TV     Product Theatre

Displaying One Session

Session Type
Clinical/Therapeutic
Date
Sat, 04.06.2022
Session Time
15:30 - 17:00
Room
On Demand 1
Session Description
The low recovery rate in schizophrenia is correlated to the residual symptomatology developing in about 50% of patients in the course of the illness. A core feature of these residual symptoms consist of cognitive dysfunction which can well be determined but is very difficult to treat. P Garety summarizes the effect of psychotherapeutic interventions on cognitive deficits beyond cognitive remediation, F. Padberg researches the literature of NIBS to see wether there is an effect of this method on cognitive functioning in schizophrenia. A Yung will demonstrate that aerobic exercise improves cognitive dysturbance in psychotic illness significantly, but will search wether these effects endure. W. Fleischhacker will not only review current pharmacological options to treat cognitive dysfunction in schizophrenia, but will present data on a Glycin-Transporter Antagonist of Boehringer-Ingelheim showing a nice effect on cognition.
Session Icon
On Demand

Psychotherapy of Biases in Cognition in Schizophrenia: the SlowMo Randomised Controlled Trial for Paranoia, Outcomes and Mechanisms

Session Type
Clinical/Therapeutic
Date
Sat, 04.06.2022
Session Time
15:30 - 17:00
Room
On Demand 1
Session Icon
On Demand
Lecture Time
15:30 - 15:50

Abstract

Abstract Body

Reasoning biases, specifically jumping to conclusions and belief inflexibility, may play a causal role in persistent paranoia. SlowMo, a new digitally supported blended cognitive-behavioural therapy, targets these biases. Adopting the terms ‘fast’ and ‘slow thinking’ as a heuristic to support therapy, SlowMo encourages people to notice a tendency to fast thinking, and to slow down for a moment to reduce paranoia. SlowMo therapy is the first digital blended therapy for paranoia, employing face to face therapy sessions with interactive digital content, and using mobile technology to promote generalisation to daily life.

We report a randomised controlled trial with N=362 participants with distressing and persistent (3+months) paranoia, comparing 8 sessions of SlowMo plus Treatment as Usual (TAU) with TAU alone. We examined SlowMo’s effectiveness in reducing paranoia and improving reasoning biases; its mechanisms of action; usability; and acceptability (Garety et al., 2021).

Outcomes: SlowMo was beneficial for paranoia: 10 /11 paranoia measures at 12 weeks and 8/11 at 24 weeks demonstrated significant effects, and sustained moderate effects were observed on all observer-rated measures of persecutory delusions. Improvements in self-esteem, worry, wellbeing and quality of life were also reported.

Mediation: Consistent with the theory-driven design and treatment rationale, improvements in slower thinking were found to mediate change in paranoia at 12- and 24-week follow-ups. However contrary to hypothesis, reduced fast thinking did not mediate change in paranoia, whereas worry did. These findings highlight the potential therapeutic mechanisms of action of SlowMo which which are discussed further.

Garety P, Ward T, Emsley R, et al. Effects of SlowMo, a Blended Digital Therapy Targeting Reasoning, on Paranoia Among People With Psychosis: A Randomized Clinical Trial. JAMA Psychiatry. 2021;78(7):714–725. doi:10.1001/jamapsychiatry.2021.0326

Hide

Is Non-Invasive Brain Stimulation (NIBS) Effective?

Session Type
Clinical/Therapeutic
Date
Sat, 04.06.2022
Session Time
15:30 - 17:00
Room
On Demand 1
Session Icon
On Demand
Lecture Time
15:50 - 16:10

Pharmacotherapy Including and Beyond Newer Antipsychotics and Antidepressants

Session Type
Clinical/Therapeutic
Date
Sat, 04.06.2022
Session Time
15:30 - 17:00
Room
On Demand 1
Session Icon
On Demand
Lecture Time
16:10 - 16:30